🇯🇵 PASIREOTIDE PAMOATE in Japan

PASIREOTIDE PAMOATE (PASIREOTIDE PAMOATE) regulatory status in Japan.

Marketing authorisation

PMDA

  • Application: Signifor Partial Change Approval
  • Local brand name: Signifor Partial Change Approval
  • Status: approved

Read official source →

PASIREOTIDE PAMOATE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is PASIREOTIDE PAMOATE approved in Japan?

Yes. PMDA has authorised it.

Who is the marketing authorisation holder for PASIREOTIDE PAMOATE in Japan?

Marketing authorisation holder not available in our data.